Conjugation reactions
AssigneeBiocompatibles UK Limited
InventorsAndrew Lewis, Simon Leppard
Life of this patent
Estimating the term…
Abstract
An initiator for the terminal group of the polymer product of an atom or gruop radical transfer polymerisation has an activated carboxyl or an amine group which is reacted with an amine or carboxyl (respectively) group containing biologically active compound. The initiator is preferably 4-(3-(2-bromo, 2-methyl-propionate)phenyl)-propionic acid N-hydroxysuccinimide ester or 2-bromo, 2-methyl-propionic acid N-hydroxysuccinimide ester. The monomers preferably comprise a zwitterionic monomer such as 2-methacryloxyethyl-2′-trimethyl ammoniumethyl phosphate inner salt.
Claims58
1-43. (canceled)
A process forming a biologically active conjugate compound comprising conjugation step in which a biologically active starting material of the general formula I
- is reacted in an amide bond forming step with a reagent of the general formula II
- to form an amide-linked conjugate,
- in which R is a biologically active moiety;
- L1 is a bond or a divalent organic linker;
- and
- X1 is —NHR6 or —COR7, in which R6 is selected from the group consisting of hydrogen, C1-6 alkyl, aryl and amine activating group and R7 is hydroxyl or a carboxyl activating group;
- X2 is selected from the group consisting of a polymer formed from ethylenically unsaturated monomers and joined through a terminal group, Cl, Br, I, OR10, SR14, SeR14, OP(═O)R14, OP(═O)(OR14)2, O—N(R14)2 and S—C(═S)N(R14)2, where R10 is alkyl of from 1 to 20 carbon atoms in which each of the hydrogen atoms may be independently replaced by halide, R14 is aryl or a straight or branched C1-C20 alkyl group, and where an N(R14)2 group is present, the two R14 groups may be joined to form a 5- or 6-membered heterocyclic ring;
- R1 and R2 are each independently selected from the group consisting of H, halogen, C1-C20 alkyl, C3-C8 cycloalkyl, C(═O)R15, C(═O)NR16R17, COCl, OH, CN, C2-C20 alkenyl, oxiranyl, glycidyl, aryl, heterocyclyl, aralkyl and aralkenyl, in any of which the alkyl, alkenyl or aryl, heterocyclyl or cycloalkyl groups there may be from 1 to 3 substituents selected from the group consisting of hydrogen, hydroxy C1-C4 alkoxy, acyloxy, aryl, heterocyclyl, C(═O)R15, C(═O)NR16R17, oxyranyl and glycidyl;
- R15 is selected from the group consisting of alkyl of from 1 to 20 carbon atoms, alkoxy of from 1 to 20 carbon atoms, oligo(alkoxy) in which each alkoxy group has 1 to 3 carbon atoms, aryloxy and heterocyclyloxy, any of which groups may have substituents selected from the group consisting of optionally substituted alkoxy, oligoalkoxy, amino and hydroxyl groups;
- R16 and R17 are independently selected from the group consisting of H and alkyl of from 1 to 20 carbon atoms which alkyl groups, may have substituents selected from the group consisting of alkoxy, acyl, acyloxy, alkoxycarbonyl, alkenoxycarbonyl, aryl and hydroxy, or R16 and R17 may be joined together to form an alkanediyl group of from 2 to 5 carbon atoms, thus forming a 3- to 6-membered ring;
- R3 and R4 are independently selected from the group consisting of hydrogen, and C1-6 alkyl, or R3 and R4 together are ═O or ═NR8 where R8 is hydrogen or C1-4 alkyl;
- R5 is selected from the group consisting of a bond, —O—, —S— and divalent organic groups;
- L2 is a bond or a divalent linker and,
- where X1 is NHR6, X3 is COR7 and
- where X1 is COR7, X3 is NHR6 and
- r is an integer of at least 1.
An amide-linked conjugate compound of the general formula XII
- where B1 is —CONR6— or —NR6—CO—;
- t is in the range 1 to r;
- r is an integer of more than 1;
- R is a biologically active moiety;
- L1 is a bond or a divalent organic linker;
- X2 is selected from the group consisting of a polymer formed from ethylenically unsaturated monomers and joined through a terminal group, Cl, Br, I, OR10, SR14, SeR14, OP(═O)R14, OP(═O)(OR14)2, O—N(R14)2 and S—C(═S)N(R14)2, where R10 is alkyl of from 1 to 20 carbon atoms in which each of the hydrogen atoms may be independently replaced by halide, R14 is aryl or a straight or branched C1-C20 alkyl group, and where an N(R14)2 group is present, the two R14 groups may be joined to form a 5- or 6-membered heterocyclic ring;
- R1 and R2 are each independently selected from the group consisting of H, halogen, C1-C20 alkyl, C3-C8 cycloalkyl, C(═O)R15, C(═O)NR16R17, COCl, OH, CN, C2-C20 alkenyl, oxiranyl, glycidyl, aryl, heterocyclyl, aralkyl and aralkenyl, in any of which the alkyl, alkenyl or aryl, heterocyclyl or cycloalkyl groups there may be from 1 to 3 substituents selected from the group consisting of hydrogen, hydroxy, C1-C4 alkoxy, acyloxy, aryl, heterocyclyl, C(═O)R15, C(═O)NR16R17, oxyranyl and glycidyl;
- R15 is selected from the group consisting of alkyl of from 1 to 20 carbon atoms, alkoxy of from 1 to 20 carbon atoms, oligo(alkoxy) in which each alkoxy group has 1 to 3 carbon atoms, aryloxy and heterocyclyloxy, any of which groups may have substituents selected from the group consisting of optionally substituted alkoxy, oligoalkoxy, amino and hydroxyl groups;
- R16 and R17 are independently H or alkyl of from 1 to 20 carbon atoms which alkyl groups, may have substituents selected from the group consisting of alkoxy, acyl, acyloxy, alkoxycarbonyl, alkenoxycarbonyl, aryl and hydroxy, or R16 and R17 may be joined together to form an alkanediyl group of from 2 to 5 carbon atoms, thus forming a 3- to 6-membered ring;
- R3 and R4 are independently selected from the group consisting of hydrogen and C1-6 alkyl, or R3 and R4 together are ═O or ═NR8 where R8 is hydrogen or C1-4 alkyl;
- R5is selected from the groups consisting of a bond, —O—, —S— and divalent organic groups;
- and
- L2 is a bond or a divalent linker.
A polymerisation process in which ethylenically unsaturated monomers are polymerised by atom or group radical transfer polymerisation in the presence of an initiator selected from 4-(3-(2-bromo, 2-methyl-propionate)phenyl)-propionic acid N-hydroxysuccinimide ester and 2-bromo, 2-methyl-propionic acid N-hydroxysuccinimide ester to form a polymer product having an N-hydroxysuccinimide ester terminal group.
2-bromo-2-methyl-propionic acid N-hydroxysuccinimide ester.
Dependencies are inferred from the claim text.